Skip to Main Content

WASHINGTON — The drug industry’s lobbying group is calling on its lobbyists to push back on a potential budget deal that reportedly includes drug pricing reforms that will cost the industry $115 billion.

In an email sent Thursday night to lobbyists both inside and outside the organization and obtained by STAT, PhRMA urged its small army of advocates to do all they can to block the potential deal, which is quickly becoming intertwined with a must pass, multibillion-dollar budget deal.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!